Just had my 3rd bagger stock since Aug. August recommendation was Lexicon Pharmaceuticals $LXRX +300% in 101 days, September recommendation was Clovis Oncology $192% in 81 days, and now La Jolla Phharmaceutical $LJPC from end of November up 100% in 42 days. I did all this with some portion of the funds coming from selling 100% of $PLX... the company I recommended in Dec 2016 that became a 3-bagger in less than 4 months. Still waiting on that dilution event for Protalix before looking at possible re-entry. We'll see what happens first... more dilution or some kind of great news drop to drive the price higher from here.
$LXRX Nobody could have guessed the 8 yes/ 8 No verdict of the FDA Advisory Board . Lawsuits are laughable as Markets go up and down. Lexicon is following regulatory pathways. They've got a great Diabetes drug . Black box warnings are always advised for patient safety. The FDA will decide on March 22nd. I like this company ,but what is more important Sanofi believes in them . Let's be patient !
$LXRX up 4.49% today to $5.35...Love all the sell advice. Will most likely double in price on 4/22/19 when it becomes the next diabetes drug to go around the world . Mark my words .
Congrats to those with stable nerves and who didn't sell lol
N
$LXRX conversation
will be bought out within a month! mark this post!
F
$LXRX conversation
Please go back to the old message board>>> The current board is not user friendly>>>
r
$LXRX conversation
Yahoo's new format sucks. Can't find anything. Where did the message board go? Where's the news?
T
$LXRX conversation
When it comes to finding the best new opportunities from across the markets there simply isn’t a better service out there than ExplosiveOTC. www.explosiveotc.com
ExplosiveOTC || Penny Stock Alert Service
www.explosiveotc.com
T
$LXRX conversation
Speaking from a science perspective... the recent phase 2 mean changes in A1c mirrored the prior studies, but did not reach statistical significance. Could this be due to the small sample size of less than 90 people? I don't think the study is sufficiently powered to find a statistically significant change.
A
$LXRX conversation
looks like all the free stop loss shares have been collected! Time to head up to collect the limit orders now!
note the low volume!
W
$LXRX conversation
Latest short interests data from NASDAQ. It only wend down by 5% or 840K shares to 14.733MM shares, which is about 15% outstanding shares. When short squeeze comes, it going to be a violent one!
Settlemnet Date Short Interests Ave. Daily Volume Days to Cover 03/31/17 14,733,516 811,775 18.15 03/15/17 15,572,934 1,607,017 9.69 02/28/17 13,177,898 828,070 15.91 02/15/17 13,081,993 737,678 17.73 01/31/17 11,736,507 497,339 23.60 01/13/17 12,233,453 938,860 13.03 12/30/16 12,498,959 791,135 15.80
13$ new PT by citi . . It will fly now again
note the low volume!
Settlemnet Date Short Interests Ave. Daily Volume Days to Cover
03/31/17 14,733,516 811,775 18.15
03/15/17 15,572,934 1,607,017 9.69
02/28/17 13,177,898 828,070 15.91
02/15/17 13,081,993 737,678 17.73
01/31/17 11,736,507 497,339 23.60
01/13/17 12,233,453 938,860 13.03
12/30/16 12,498,959 791,135 15.80